Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis

NCT05452850 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-09-28

No results posted yet for this study

Summary

The purpose of this study to assess the longitudinal changes in left and right ventricular global strain after chemotherapeutic strategies in cardiac light chain amyloidosis.

Conditions

  • Amyloid Cardiomyopathy
  • Congestive Heart Failure
  • Chemotherapy Effect

Interventions

DIAGNOSTIC_TEST

Left and Right Ventricular Global Strain Imaging

Two-dimensional, color Doppler, spectral Doppler, and 3D digital echocardiographic image recordings will be taken from parasternal, apical, subcostal, and modified sections using a Philips Epiq CVx echocardiography device and X5-1 probe. Conventional parameters, additional parameters, and strain analyzes will be performed with speckle tracking echocardiography from these recordings.

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Burçak Kılıçkıran Avcı, Assoc Prof. · Istanbul University - Cerrahpasa

  • Deniz Mutlu, MD · Istanbul University - Cerrahpasa

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-11
Primary Completion
2023-09-26
Completion
2023-10-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05452850 on ClinicalTrials.gov